The science behind Simtriyo, the first ADHD medication to target three major neurotransmitters
Centanafadine represents a new class of ADHD medication that uniquely targets three major brain chemicals. By preventing the reuptake of dopamine, noradrenaline, and serotonin, the daily tablet reduces hyperactivity while potentially offering broader mood-regulating benefits.
We haven't written up this one. PsyPost has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
